BSP Pharmaceuticals is proud to announce Its participation to the 14th European edition of World ADC Summit of London 2024.
The 14th Annual World ADC of London will explore the updates on linker-payload optimisation, novel target discovery, toxicity reduction, combination partner selection, and manufacturing acceleration to streamline CMC Strategy to accelerate ADCs to Earlier-Line Treatments.
These insights will provide the know-how to drive more ADCs to approval and ultimately to front-line treatments. The summit will split into 5 Streams with 5 complimentary Seminar Days and 8 deep-diving workshops, joining 600+ attendees to navigate the challenges and opportunities in the exciting world of antibody-drug conjugates.
Save the Date!!! Next Wednesday, 13th of March, our Giorgio Salciarini – Marketing & Development Business Manager – will present its speech: “Our history to serve the Innovators: a step ahead against the Challenges of Bioconjugate” during the Conference Day1, starting from 17:00 PM
To request a meeting and for any info, You can send an e-mail at Business.Development@Bsppharmaceuticals.com
